National observatory for interventional cardiology in France

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to rigorously assess clinical practices in interventional cardiology to enhance patient care and outcomes. It involves a multicentric approach across five catheterization laboratories in the Centre Val de Loire region, collecting and evaluating data on patients who have undergone coronary angiograms or angioplasties. The data collected will contribute to a comprehensive database that can be utilized to improve practices and potentially expand to other regions in France.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age =\>18 years at enrollment
* Patient who have had a coronary angiogram or angioplasty

Exclusion Criteria:

* Patient who didn't want to participated

Where it's running

• Research Cardiology Unit / Les hopitaux de Chartres
  Le Coudray, Eure Et Loire, France Recruiting
• Centre Hospitalier Henri Mondor d'Aurillac
  Aurillac, France Recruiting
• Centre Hospitalier Jacques Coeur de Bourges
  Bourges, France Recruiting
• CHU Caen - Hôpital Côte de Nacre
  Caen, France Recruiting
• CHRU Hôpitaux de Tours - Trousseau
  Chambray-lès-Tours, France Recruiting
• CHU Gabriel-Montpied de Clermont-Ferrand
  Clermont-Ferrand, France Recruiting

Study contacts

• Study coordinator: Gregoire Range, MD
• Email: registrecrac@ch-chartres.fr

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early single antiplatelet therapy after IVUS-guided PCI in ACS

  This study tests whether stopping aspirin early and continuing a potent P2Y12 inhibitor alone is safe and effective after IVUS-guided PCI in people with acute coronary syndrome.

  Recruiting Phase 4 Gyeongsang National University Hospital · Jinju, Gyeongsangnam-do · NCT07684742

• Early LDL-C lowering with evolocumab after ACS to see if it slows plaque progression

  This trial tests whether starting evolocumab soon after a heart attack or unstable angina, in addition to standard therapy, reduces non-culprit plaque growth over a year.

  Recruiting Phase 4 West China Hospital · Xi’an, Shanxi and 1 other locations · NCT07612774

• Seeing if short education videos help families understand pediatric heart conditions and speed up visits

  Short educational videos shown during pediatric cardiology visits are being tested to see if they help families understand their child's heart condition and make clinic visits run more smoothly.

  Recruiting Driscoll Children's Hospital · San Antonio, Texas · NCT07594041

• Drug-coated balloon treatment during emergency angioplasty for STEMI

  This registry will try using drug-coated balloons instead of stents during emergency PCI for people with ST-elevation heart attacks to see how the procedure and patient outcomes compare.

  Recruiting Medical University of Vienna · Vienna · NCT07436429

• Early intravenous landiolol to limit heart muscle damage after STEMI

  This study tries early IV landiolol versus standard oral beta-blockers to see if it reduces the amount of heart muscle damage in adults with STEMI who undergo primary PCI.

  Recruiting Aristotle University Of Thessaloniki · Thessaloniki, Thessaloniki · NCT07293832

• Building a short video and audio database of cancer pain to help AI recognize patient pain

  This project collects short face and voice recordings from adults with cancer who do and don't have pain to help test AI that tries to recognize pain from expressions.

  Recruiting Erasmus Medical Center · Rotterdam, South Holland · NCT07262632

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.